hydroxyurea has been researched along with Parotid Neoplasms in 2 studies
Parotid Neoplasms: Tumors or cancer of the PAROTID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyurea is a ribonucleotide diphosphate reductase inhibitor used in the treatment of patients with myeloproliferative disorders." | 1.32 | Metastatic squamous cell carcinoma of the skin in chronic myeloid leukaemia: complication of hydroxyurea therapy. ( Altaner, S; Demir, M; Pamuk, GE; Tek, M; Turgut, B; Vural, O, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pamuk, GE | 1 |
| Turgut, B | 1 |
| Vural, O | 1 |
| Demir, M | 1 |
| Tek, M | 1 |
| Altaner, S | 1 |
| Richards, GJ | 1 |
| Chambers, RG | 1 |
2 other studies available for hydroxyurea and Parotid Neoplasms
| Article | Year |
|---|---|
Metastatic squamous cell carcinoma of the skin in chronic myeloid leukaemia: complication of hydroxyurea therapy.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Leukemia, Myelogenous, C | 2003 |
Hydroxyurea in the treatment of neoplasms of the head and neck. A resurvey.
Topics: Administration, Oral; Ear Neoplasms; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hydroxyurea | 1973 |